Armor Medical Inc., a startup company developing a biomedical device that enables diagnosis of early hemorrhage, has won the Global Impact Award and $25,000 in nondilutive funding from the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship at Washington University in St. Louis.
Christine O’Brien, assistant professor of biomedical engineering in the McKelvey School of Engineering, co-founded Armor Medical with Leonid Shmuylovich, MD, PhD, assistant professor of dermatology at Washington University School of Medicine, and Kelsey Mayo, CEO of Armor Medical Inc.
The Global Impact Award recognizes scalable, sustainable, for-profit and quick-to-market ventures with a proof of concept for a broad impact. The company created the device, Maternal aRMOR, for obstetric providers who need to identify patients at risk for postpartum hemorrhage to facilitate early treatment.
“This year’s pool of Global Impact Award startups was more competitive than any previous years,” said II Luscri, managing director of the Skandalaris Center and assistant vice provost for innovation & entrepreneurship. “Armor’s technology and team truly separated them from the pack. They have been involved with the Skandalaris Center for some time now, and we are excited to continue to support them on their journey.”